About
Kari Anne Sveen
Position: MD, PhD, post doc
Place of work: Department of Endocrinology, Morbid Obesity & Preventive Medicine - Oslo University Hosptial, Aker
E-mail: k.a.sveen@medisin.uio.no
Phone: +47 23033430/ + 47 92069987
Groups
Childhood diabetes - Knut Dahl-Jørgensen
Diabetic late complications - Tore Julsrud Berg
Current research focus
Long term vascular changes and complications of type 1 diabetes- clinical aspects and biological markers. This is a 27 year follow up of the “Oslo study”
Publications
Holte, K. B., M. Svanteson, K. F. Hanssen, K. A. Sveen, I. Seljeflot, S. Solheim, D. R. Sell, V. M. Monnier, and T. J. Berg. "Collagen Methionine Sulfoxide and Glucuronidine/Lw-1 Are Markers of Coronary Artery Disease in Long-Term Survivors with Type 1 Diabetes. The Dialong Study." [In eng]. PLoS One 15, no. 5 (2020): e0233174. https://doi.org/10.1371/journal.pone.0233174.
Sveen, K. A., K. Dahl-Jørgensen, K. H. Stensaeth, K. Angel, I. Seljeflot, D. R. Sell, V. M. Monnier, and K. F. Hanssen. "Glucosepane and Oxidative Markers in Skin Collagen Correlate with Intima Media Thickness and Arterial Stiffness in Long-Term Type 1 Diabetes." [In eng]. J Diabetes Complications 29, no. 3 (Apr 2015): 407-12. https://doi.org/10.1016/j.jdiacomp.2014.12.011.
Sveen, K. A., T. Nerdrum, K. F. Hanssen, M. Brekke, P. A. Torjesen, C. M. Strauch, D. R. Sell, et al. "Impaired Left Ventricular Function and Myocardial Blood Flow Reserve in Patients with Long-Term Type 1 Diabetes and No Significant Coronary Artery Disease: Associations with Protein Glycation." [In eng]. Diab Vasc Dis Res 11, no. 2 (Mar 2014): 84-91. https://doi.org/10.1177/1479164113518805.
Sveen, K. A., B. Karimé, E. Jørum, S. I. Mellgren, M. W. Fagerland, V. M. Monnier, K. Dahl-Jørgensen, and K. F. Hanssen. "Small- and Large-Fiber Neuropathy after 40 Years of Type 1 Diabetes: Associations with Glycemic Control and Advanced Protein Glycation: The Oslo Study." [In eng]. Diabetes Care 36, no. 11 (Nov 2013): 3712-7. https://doi.org/10.2337/dc13-0788.
Fraser, D. A., L. M. Diep, I. A. Hovden, K. B. Nilsen, K. A. Sveen, I. Seljeflot, and K. F. Hanssen. "The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients with Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial." [In eng]. Diabetes Care 35, no. 5 (May 2012): 1095-7. https://doi.org/10.2337/dc11-1895.